Tag Archives: fidelity-select

5 Top-Rated Healthcare Mutual Funds To Add To Your Portfolio

Healthcare mutual funds provide excellent choices for investors looking to enter this safe-haven sector, which is likely to protect their investment during a market downturn. The healthcare sector has proven to be one of the most desirable avenues during difficult times as it does not vary with market conditions. Also, several pharmaceutical companies have a history of paying regular dividends, which can help to offset the losses from plummeting share prices. Below we will share with you 5 top-ranked healthcare mutual funds. Each has earned a Zacks #1 Rank (Strong Buy) as we expect these mutual funds to outperform their peers in the future. Fidelity Select Health Care Portfolio (MUTF: FSPHX ) seeks capital growth over the long run. FSPHX invests a major portion of its assets in companies involved in designing, manufacturing and selling healthcare products and services. FSPHX invests in companies across the world. The Fidelity Select Health Care Portfolio is a non-diversified fund and has returned 10.6% over the past one year. FSPHX has an expense ratio of 0.74% as compared to a category average of 1.35%. Fidelity Select Biotechnology Portfolio (MUTF: FBIOX ) invests a large share of its assets in companies primarily involved in research, development, manufacture and distribution of various biotechnological products. Factors such as financial strength and economic conditions are considered to invest in companies located anywhere in the world. The Fidelity Select Biotechnology Portfolio is a non-diversified fund and has returned 22.7% over the past one year. Rajiv Kaul is the fund manager and has managed FBIOX since 2005. Turner Medical Sciences Long/Short C (MUTF: TMSCX ) seeks capital appreciation. TMSCX invests a major chunk of its assets in healthcare firms. TMSCX uses a long/short growth strategy for reduction of volatility and capital preservation during a market downturn. TMSCX mainly focuses on acquiring securities of companies having market capitalizations greater than $250 million. TMSCX is expected to maintain a portfolio of 15 to 75 securities long, and 15 to 75 securities short. The Turner Medical Sciences Long/Short C has returned 11.1% over the past one year. TMSCX has an expense ratio of 1.50% as compared to a category average of 1.84%. Fidelity Select Medical Delivery Portfolio (MUTF: FSHCX ) invests largely in companies that either own or are involved in operating hospital and nursing homes, and are related to the healthcare services sector. FSHCX focuses on acquiring common stocks of both US and non-US companies. The Fidelity Select Medical Delivery Portfolio fund is non-diversified and has returned 19.9% over the last one-year period. Steven Bullock is the fund manager and has managed FSHCX since 2012. Fidelity Select Medical Equipment & Systems (MUTF: FSMEX ) seeks capital growth. FSMEX invests the majority of its assets in companies that are primarily involved in medical equipment and devices and the related technologies sector. FSMEX focuses on acquiring common stocks of companies by analyzing factors including financial strength and economic condition. FSMEX invests in both US and non-US companies. The Fidelity Select Medical Equipment & Systems is a non-diversified fund and has returned almost 14.3% over the past one year. As of August 2015, FSMEX held 55 issues with 23.57% of its assets invested in Medtronic PLC. Original Post

3 Retail Mutual Funds To Gain From Consumer Spending Surge

Retail is one of the main sectors that benefits from higher consumer spending as expenditures in the retail sector represents almost 30% of the consumer spending, which has increased significantly in recent times. After surfacing as one of the few bright spots in the first-quarter GDP report, consumer spending was the mainstay of the economy in the second. Consumer expenditure is likely to continue this positive trend on the back of strong economic fundamentals including robust labor-market condition, increase in wages and slump in oil prices. Moreover, the second-quarter earnings performance from the retail sector also confirms the bullish trend. Hence, investors may consider retail mutual funds with strong fundamentals in order to gain from this favorable economic environment. Below we will share with you 3 buy-ranked retail mutual funds. Each has earned either a Zacks Mutual Fund Rank #1 (Strong Buy) or a Zacks Mutual Fund Rank #2 (Buy) as we expect these mutual funds to outperform their peers in the future. Fidelity Select Consumer Discretionary Portfolio (MUTF: FSCPX ) normally invests a lion’s share of its assets in securities of companies mostly involved in the consumer discretionary sector. FSCPX primarily invests in common stocks of companies all over the globe. Factors including financial strength and economic condition are considered before investing in a company. The Fidelity Select Consumer Discretionary Portfolio is non-diversified fund and has returned 9.2% in the last one year. Peter Dixon is the fund manager and has managed FSCPX since 2014. Fidelity Select Retailing Portfolio (MUTF: FSRPX ) seeks growth of capital. FSRPX invests a large chunk of its assets in securities of retailing companies that are traded within the domestic boundary. FSRPX may also invest in derivatives including futures contracts and options. FSRPX invests a notable share of its assets in small- and mid-cap companies. FSRPX may consider ADRs to invest in foreign companies and securities issued by the US government. The Fidelity Select Retailing Portfolio fund has returned 8.2% in the last one year. FSRPX has an expense ratio of 0.81% as compared to category average of 1.46%. Putnam Global Consumer A (MUTF: PGCOX ) invests in mid-to-large companies that are involved in the manufacture, sale or distribution of consumer staples and consumer discretionary products and services. PGCOX uses “blend” strategy to invest in common stocks of companies. The Putnam Global Consumer A fund has returned 2.4% in the last one year. As of June 2015, PGCOX held 96 issues with 6.61% of its assets invested in Amazon.com (NASDAQ: AMZN ). Original Post Share this article with a colleague

3 Healthcare Mutual Funds Poised For A Surge

The healthcare sector is coming off a strong Q1 of 2015, with over 80% of the companies in the sector beating earnings estimates. The recent success of this sector is partially the result of the Affordable Care Act. Another positive for this sector is that the demand for such services usually remains unchanged even during an economic downturn and investments in the sector provide sufficient protection to the capital invested. Healthcare mutual funds provide the perfect avenue for investors looking to invest in this sector. Below we will share with you 3 top healthcare mutual funds. Each has earned either a Zacks #1 Rank (Strong Buy) or a Zacks #2 Rank (Buy) as we expect these mutual funds to outperform their peers in the future. VALIC Company I Health Sciences (MUTF: VCHSX ) invests a majority of its assets in common stocks of healthcare products, medicine or life sciences related companies. VCHSX focuses mainly on investing in large and mid-cap companies. A maximum of 35% of VCHSX’s assets is invested foreign companies. The VALIC Company I Health Sciences fund has returned 46.2% over the past one year. Taymour R. Tamaddon is the fund manager and has managed VCHSX since 2013. Fidelity Select Health Care Portfolio (MUTF: FSPHX ) seeks capital growth over the long run. FSPHX invests a lion’s share of its assets in companies involved in designing, manufacturing and selling of healthcare products and services. FSPHX invests in companies throughout the globe. The Fidelity Select Health Care Portfolio is non-diversified fund and has returned 40.6% over the past one year. FSPHX has an expense ratio of 0.74% as compared to category average of 1.37%. Fidelity Select Biotechnology Portfolio (MUTF: FBIOX ) invests a lion’s share of its assets in companies primarily involved in research, development, manufacture, and distribution of various biotechnological products. Factors such as financial strength and economic condition are considered to invest in companies located all over the world. The Fidelity Select Biotechnology Portfolio is non-diversified fund and has returned 59.7% over the past one year. As of March 2015, this fund held 214 issues with 8.16% of its assets invested in Biogen Inc. Original Post Share this article with a colleague